首页> 中文期刊> 《分子细胞生物学报:英文版》 >New discoveries in obesity and related metabolic diseases:from bench to bed

New discoveries in obesity and related metabolic diseases:from bench to bed

         

摘要

Obesity,and other metabolic diseases including non-alcoholic fatty liver disease(NAFLD),metabolic syndrome(MetS),type 2 diabetes mellitus(T2DM)and its related complications like chronic kidney disease(CKD),and hepatocellular carcinoma(HCC)have led to alarming health and social burdens globally and in China as well.Although strong links exist among those multifactorial metabolic disorders,there are limited researches on better understanding of their pathogenesis and the provision of effective interventional measures in practice.In this special issue,we have five researches including three research articles providing new insights into potential mechanisms in the development and possible prevention and treatment therapies of NAFLD,HCC,and CKD,as well as two review articles summarizing multi-omics profiling and future strategies for precision medicine in T2DM,NAFLD,and MetS,and the rapid advances in the field of metabolic surgery in China.

著录项

  • 来源
    《分子细胞生物学报:英文版》 |2021年第8期|P.541-542|共2页
  • 作者

    Weiping Jia;

  • 作者单位

    Department of Endocrinology and Metabolism Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai 200233 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 消化系及腹部疾病;
  • 关键词

    diseases; prevention; obesity;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号